South Korea Cell Culture Market by Product (Consumables and Instruments), Application (Stem Cell Technology, Cancer Research, Drug Screening and Development, Tissue Engineering & Regenerative Medicine, and Others), and End User (Research Institutes, Pharmaceutical & Biotechnology Companies, and Others): Opportunity Analysis and Industry Forecast, 2020–2027
The Saudi Arabia cell culture market accounted for $216.3 million in 2019, and is expected to reach $606.4 million by 2027, registering a CAGR of 13.7% from 2020 to 2027.
A cell culture is defined as the distribution of cells in an artificial environment (in vitro). This artificial environment is composed of all the necessary nutrients, ideal temperature, gases, pH, and humidity, which are essential for the growth and proliferation of the cells. The cells for the process are obtained from either plant or animals. Different types of tools and machines are employed in producing a cell culture. These machines are also known as instruments. For instance, some of the instruments, which are used to produce cell culture include bioreactors, cell culture vessels, and others. Further, different types of chemicals are also employed in the production of a cell culture.
These chemicals are also referred as consumables, as they are completely used during the process. Some of the consumables used in the process include sera, reagents, and others. Cell cultures are of a great importance and hence find their use in fields such as cancer research, stem cell technology, and others. For instance, in cancer research, cell cultures enable investigators to tap a renewable source of stable tumor cells for various experiments. In addition, different types of industries use instruments and consumables to make cell cultures such as research institutes, pharmaceutical & biotechnology companies, and others. The major factors that contribute toward the growth of the cell culture market include surge in prevalence of cancer and rise in adoption of cell culture technique.
Furthermore, factors such as surge in awareness related to the use of cell culture technique in research and increase in research-related funding also help boost the market growth. In addition, surge in cancer-related research is another major factor that fuels the growth of the market. However, high capital investment and lack of infrastructure for cell-based research are anticipated to restrain the cell culture market growth during the forecast period. On the contrary, expected rise in demand for advanced cell culture technologies offers lucrative opportunity for the cell culture market growth.
The South Korea cell culture market is segmented on the basis of product, application, and end user to provide a detailed assessment of the market. By product, the market is divided into consumables and instruments. The consumables segment is further categorized into sera, media, reagents, and bioreactor accessories. The instruments segment is further sub-segmented into bioreactors, cell culture vessels, cell culture storage equipment, and cell culture supporting instruments. The consumables segment dominated the market in terms of revenue in 2019, owing to higher consumption of cell culture consumables along with repeated purchase of cell culture consumables as compared to cell culture instruments.
Based on application, the market is classified into stem cell technology, cancer research, drug screening & development, tissue engineering & regenerative medicine, and others. The tissue engineering & regenerative medicine segment spearheaded the market in 2019, and is expected to continue this trend during the forecast period as tissue engineering specializes in repairing damaged tissues by injecting new one generated by 3D cell culture. This culture methods try to reduce the gap between in vitro and in vivo drug testing models as much as possible. As a result, there are more and more targeted cancer treatment available.
On the basis of end user, the market is divided into research institutes, pharmaceutical & biotechnology companies, and others. The pharmaceutical & biotechnology companies segment led the market in 2019 in terms of value. This is attributed to expansion of major pharmaceutical companies and growing regulatory approvals for the production of cell culture-based vaccines. Major players operating in the market include Avantor, Inc. (VWR International, LLC), Bio-Rad Laboratories Inc., Corning Incorporated, Danaher Corporation (Cytiva), FUJIFILM Holdings Corporation (FUJIFILM Irvine Scientific, Inc.), Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Sartorius AG, STEMCELL Technologies Inc., and Thermo Fisher Scientific Inc.
KEY BENEFITS FOR STAKEHOLDERS
By Product
A cell culture is defined as the distribution of cells in an artificial environment (in vitro). This artificial environment is composed of all the necessary nutrients, ideal temperature, gases, pH, and humidity, which are essential for the growth and proliferation of the cells. The cells for the process are obtained from either plant or animals. Different types of tools and machines are employed in producing a cell culture. These machines are also known as instruments. For instance, some of the instruments, which are used to produce cell culture include bioreactors, cell culture vessels, and others. Further, different types of chemicals are also employed in the production of a cell culture.
These chemicals are also referred as consumables, as they are completely used during the process. Some of the consumables used in the process include sera, reagents, and others. Cell cultures are of a great importance and hence find their use in fields such as cancer research, stem cell technology, and others. For instance, in cancer research, cell cultures enable investigators to tap a renewable source of stable tumor cells for various experiments. In addition, different types of industries use instruments and consumables to make cell cultures such as research institutes, pharmaceutical & biotechnology companies, and others. The major factors that contribute toward the growth of the cell culture market include surge in prevalence of cancer and rise in adoption of cell culture technique.
Furthermore, factors such as surge in awareness related to the use of cell culture technique in research and increase in research-related funding also help boost the market growth. In addition, surge in cancer-related research is another major factor that fuels the growth of the market. However, high capital investment and lack of infrastructure for cell-based research are anticipated to restrain the cell culture market growth during the forecast period. On the contrary, expected rise in demand for advanced cell culture technologies offers lucrative opportunity for the cell culture market growth.
The South Korea cell culture market is segmented on the basis of product, application, and end user to provide a detailed assessment of the market. By product, the market is divided into consumables and instruments. The consumables segment is further categorized into sera, media, reagents, and bioreactor accessories. The instruments segment is further sub-segmented into bioreactors, cell culture vessels, cell culture storage equipment, and cell culture supporting instruments. The consumables segment dominated the market in terms of revenue in 2019, owing to higher consumption of cell culture consumables along with repeated purchase of cell culture consumables as compared to cell culture instruments.
Based on application, the market is classified into stem cell technology, cancer research, drug screening & development, tissue engineering & regenerative medicine, and others. The tissue engineering & regenerative medicine segment spearheaded the market in 2019, and is expected to continue this trend during the forecast period as tissue engineering specializes in repairing damaged tissues by injecting new one generated by 3D cell culture. This culture methods try to reduce the gap between in vitro and in vivo drug testing models as much as possible. As a result, there are more and more targeted cancer treatment available.
On the basis of end user, the market is divided into research institutes, pharmaceutical & biotechnology companies, and others. The pharmaceutical & biotechnology companies segment led the market in 2019 in terms of value. This is attributed to expansion of major pharmaceutical companies and growing regulatory approvals for the production of cell culture-based vaccines. Major players operating in the market include Avantor, Inc. (VWR International, LLC), Bio-Rad Laboratories Inc., Corning Incorporated, Danaher Corporation (Cytiva), FUJIFILM Holdings Corporation (FUJIFILM Irvine Scientific, Inc.), Merck KGaA, Miltenyi Biotec B.V. & Co. KG, Sartorius AG, STEMCELL Technologies Inc., and Thermo Fisher Scientific Inc.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the South Korea cell culture market size along with the current trends and future estimations to elucidate the imminent investment pockets
- It offers market analysis from 2020 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market
- A comprehensive analysis on country assists to understand the country market and facilitate the strategic business planning and determine prevailing opportunities
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the South Korea cell culture market growth
By Product
- Consumables
- Sera
- Media
- Reagents
- Bioreactor Accessories
- Instruments
- Bioreactors
- Cell Culture Vessels
- Cell Culture Storage Equipment
- Cell Culture Supporting Instruments
- Stem Cell Technology
- Cancer Research
- Drug Screening and Development
- Tissue Engineering & Regenerative Medicine
- Others
- Research Institutes
- Pharmaceutical & Biotechnology Companies
- Others
- Avantor, Inc. (VWR International, LLC)
- Bio-Rad Laboratories Inc.
- Corning Incorporated
- Danaher Corporation (Cytiva)
- FUJIFILM Holdings Corporation (FUJIFILM Irvine Scientific, Inc.)
- Merck KGaA
- Miltenyi Biotec B.V. & Co. KG
- Sartorius AG
- STEMCELL Technologies Inc.
- Thermo Fisher Scientific Inc.
- Eppendorf AG
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.2.1.List of key players profiled in the report
1.3.Research methodology
1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.1.1.Top investment pockets
3.1.2.Top winning strategies
3.2.Porter's five forces analysis
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Prevalence of cancer
3.3.1.2.Increase in adoption of cell culture technique
3.3.1.3.Increase in research funding
3.3.2.Restraints
3.3.2.1.High capital investment
3.3.2.2.Lack of infrastructure for cell-based research
3.3.3.Opportunity
3.3.3.1.Expected rise in demand for advanced technologies
3.3.4.Impact analysis
3.4.Market share analysis (South Korea culture media market, 2019)
3.5.Impact analysis of COVID-19 on the cell culture market
CHAPTER 4:SOUTH KOREA CELL CULTURE MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Consumables
4.2.1.Market size and forecast
4.2.1.1.Sera
4.2.2.Market size and forecast
4.2.2.1.Media
4.2.3.Market size and forecast
4.2.3.1.Reagents
4.2.4.Market size and forecast
4.2.4.1.Bioreactor accessories
4.2.5.Market size and forecast
4.3.Instruments
4.3.1.Market size and forecast
4.3.1.1.Bioreactors
4.3.2.Market size and forecast
4.3.2.1.Cell culture vessels
4.3.3.Market size and forecast
4.3.3.1.Cell culture storage equipment
4.3.4.Market size and forecast
4.3.4.1.Cell culture supporting instruments
4.3.5.Market size and forecast
CHAPTER 5:SOUTH KOREA CELL CULTURE MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Stem cell technology
5.2.1.Market size and forecast
5.3.Cancer research
5.3.1.Market size and forecast
5.4.Drug screening and development
5.4.1.Market size and forecast
5.5.Tissue engineering & regenerative medicine
5.5.1.Market size and forecast
5.6.Others
5.6.1.Market size and forecast
CHAPTER 6:SOUTH KOREA CELL CULTURE MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Research institutes
6.2.1.Market size and forecast
6.3.Pharmaceutical & biotechnology companies
6.3.1.Market size and forecast
6.4.Others
6.4.1.Market size and forecast
CHAPTER 7:COMPANY PROFILES
7.1.AVANTOR, INC. (VWR INTERNATIONAL, LLC)
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.2.BIO-RAD LABORATORIES INC.
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.2.6.Key strategic moves and developments
7.3.CORNING INCORPORATED
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.DANAHER CORPORATION (CYTIVA)
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments
7.5.FUJIFILM HOLDINGS CORPORATION (FUJIFILM IRVINE SCIENTIFIC, INC.)
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments
7.6.MERCK KGAA
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.6.6.Key strategic moves and developments
7.7.MILTENYI BIOTEC B.V. & CO. KG
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Key strategic moves and developments
7.8.SARTORIUS AG
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance
7.8.6.Key strategic moves and developments
7.9.STEMCELL TECHNOLOGIES INC.
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Key strategic moves and developments
7.10.THERMO FISHER SCIENTIFIC, INC.
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.10.6.Key strategic moves and developments
1.1.Report description
1.2.Key market segments
1.2.1.List of key players profiled in the report
1.3.Research methodology
1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.1.1.Top investment pockets
3.1.2.Top winning strategies
3.2.Porter's five forces analysis
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Prevalence of cancer
3.3.1.2.Increase in adoption of cell culture technique
3.3.1.3.Increase in research funding
3.3.2.Restraints
3.3.2.1.High capital investment
3.3.2.2.Lack of infrastructure for cell-based research
3.3.3.Opportunity
3.3.3.1.Expected rise in demand for advanced technologies
3.3.4.Impact analysis
3.4.Market share analysis (South Korea culture media market, 2019)
3.5.Impact analysis of COVID-19 on the cell culture market
CHAPTER 4:SOUTH KOREA CELL CULTURE MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Consumables
4.2.1.Market size and forecast
4.2.1.1.Sera
4.2.2.Market size and forecast
4.2.2.1.Media
4.2.3.Market size and forecast
4.2.3.1.Reagents
4.2.4.Market size and forecast
4.2.4.1.Bioreactor accessories
4.2.5.Market size and forecast
4.3.Instruments
4.3.1.Market size and forecast
4.3.1.1.Bioreactors
4.3.2.Market size and forecast
4.3.2.1.Cell culture vessels
4.3.3.Market size and forecast
4.3.3.1.Cell culture storage equipment
4.3.4.Market size and forecast
4.3.4.1.Cell culture supporting instruments
4.3.5.Market size and forecast
CHAPTER 5:SOUTH KOREA CELL CULTURE MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Stem cell technology
5.2.1.Market size and forecast
5.3.Cancer research
5.3.1.Market size and forecast
5.4.Drug screening and development
5.4.1.Market size and forecast
5.5.Tissue engineering & regenerative medicine
5.5.1.Market size and forecast
5.6.Others
5.6.1.Market size and forecast
CHAPTER 6:SOUTH KOREA CELL CULTURE MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Research institutes
6.2.1.Market size and forecast
6.3.Pharmaceutical & biotechnology companies
6.3.1.Market size and forecast
6.4.Others
6.4.1.Market size and forecast
CHAPTER 7:COMPANY PROFILES
7.1.AVANTOR, INC. (VWR INTERNATIONAL, LLC)
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.2.BIO-RAD LABORATORIES INC.
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.2.6.Key strategic moves and developments
7.3.CORNING INCORPORATED
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.DANAHER CORPORATION (CYTIVA)
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments
7.5.FUJIFILM HOLDINGS CORPORATION (FUJIFILM IRVINE SCIENTIFIC, INC.)
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments
7.6.MERCK KGAA
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.6.6.Key strategic moves and developments
7.7.MILTENYI BIOTEC B.V. & CO. KG
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Key strategic moves and developments
7.8.SARTORIUS AG
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance
7.8.6.Key strategic moves and developments
7.9.STEMCELL TECHNOLOGIES INC.
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Key strategic moves and developments
7.10.THERMO FISHER SCIENTIFIC, INC.
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.SOUTH KOREA CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 02.SOUTH KOREA CELL CULTURE MARKET, BY CONSUMABLES, 2019-2027 ($MILLION)
TABLE 03.SOUTH KOREA CELL CULTURE MARKET, BY INSTRUMENTS, 2019-2027 ($MILLION)
TABLE 04.SOUTH KOREA CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 05.SOUTH KOREA CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 06.AVANTOR: COMPANY SNAPSHOT
TABLE 07.AVANTOR: OPERATING SEGMENTS
TABLE 08.AVANTOR: PRODUCT PORTFOLIO
TABLE 09.BIO-RAD: COMPANY SNAPSHOT
TABLE 10.BIO-RAD: OPERATING SEGMENTS
TABLE 11.BIO-RAD: PRODUCT PORTFOLIO
TABLE 12.CORNING: COMPANY SNAPSHOT
TABLE 13.CORNING: OPERATING SEGMENT
TABLE 14.CORNING: PRODUCT PORTFOLIO
TABLE 15.CORNING: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 16.DANAHER: COMPANY SNAPSHOT
TABLE 17.DANAHER: OPERATING SEGMENTS
TABLE 18.DANAHER: PRODUCT PORTFOLIO
TABLE 19.DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 20.FUJIFILM: COMPANY SNAPSHOT
TABLE 21.FUJIFILM: OPERATING SEGMENTS
TABLE 22.FUJIFILM: PRODUCT PORTFOLIO
TABLE 23.MERCK: COMPANY SNAPSHOT
TABLE 24.MERCK: OPERATING SEGMENTS
TABLE 25.MERCK: PRODUCT PORTFOLIO
TABLE 26.MERCK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 27.MILTENYI BIOTEC: COMPANY SNAPSHOT
TABLE 28.MILTENYI BIOTEC: OPERATING SEGMENT
TABLE 29.MILTENYI BIOTEC: PRODUCT PORTFOLIO
TABLE 30.MILTENYI BIOTEC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 31.SARTORIUS: COMPANY SNAPSHOT
TABLE 32.SARTORIUS: OPERATING BUSINESS SEGMENTS
TABLE 33.SARTORIUS: PRODUCT PORTFOLIO
TABLE 34.SARTORIUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 35.STEMCELL: COMPANY SNAPSHOT
TABLE 36.STEMCELL: OPERATING SEGMENT
TABLE 37.STEMCELL: PRODUCT PORTFOLIO
TABLE 38.STEMCELL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 39.THERMO FISHER: COMPANY SNAPSHOT
TABLE 40.THERMO FISHER.: OPERATING SEGMENTS
TABLE 41.THERMO FISHER.: PRODUCT PORTFOLIO
TABLE 42.THERMO FISHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 01.SOUTH KOREA CELL CULTURE MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 02.SOUTH KOREA CELL CULTURE MARKET, BY CONSUMABLES, 2019-2027 ($MILLION)
TABLE 03.SOUTH KOREA CELL CULTURE MARKET, BY INSTRUMENTS, 2019-2027 ($MILLION)
TABLE 04.SOUTH KOREA CELL CULTURE MARKET, BY APPLICATION, 2019-2027 ($MILLION)
TABLE 05.SOUTH KOREA CELL CULTURE MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 06.AVANTOR: COMPANY SNAPSHOT
TABLE 07.AVANTOR: OPERATING SEGMENTS
TABLE 08.AVANTOR: PRODUCT PORTFOLIO
TABLE 09.BIO-RAD: COMPANY SNAPSHOT
TABLE 10.BIO-RAD: OPERATING SEGMENTS
TABLE 11.BIO-RAD: PRODUCT PORTFOLIO
TABLE 12.CORNING: COMPANY SNAPSHOT
TABLE 13.CORNING: OPERATING SEGMENT
TABLE 14.CORNING: PRODUCT PORTFOLIO
TABLE 15.CORNING: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 16.DANAHER: COMPANY SNAPSHOT
TABLE 17.DANAHER: OPERATING SEGMENTS
TABLE 18.DANAHER: PRODUCT PORTFOLIO
TABLE 19.DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 20.FUJIFILM: COMPANY SNAPSHOT
TABLE 21.FUJIFILM: OPERATING SEGMENTS
TABLE 22.FUJIFILM: PRODUCT PORTFOLIO
TABLE 23.MERCK: COMPANY SNAPSHOT
TABLE 24.MERCK: OPERATING SEGMENTS
TABLE 25.MERCK: PRODUCT PORTFOLIO
TABLE 26.MERCK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 27.MILTENYI BIOTEC: COMPANY SNAPSHOT
TABLE 28.MILTENYI BIOTEC: OPERATING SEGMENT
TABLE 29.MILTENYI BIOTEC: PRODUCT PORTFOLIO
TABLE 30.MILTENYI BIOTEC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 31.SARTORIUS: COMPANY SNAPSHOT
TABLE 32.SARTORIUS: OPERATING BUSINESS SEGMENTS
TABLE 33.SARTORIUS: PRODUCT PORTFOLIO
TABLE 34.SARTORIUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 35.STEMCELL: COMPANY SNAPSHOT
TABLE 36.STEMCELL: OPERATING SEGMENT
TABLE 37.STEMCELL: PRODUCT PORTFOLIO
TABLE 38.STEMCELL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 39.THERMO FISHER: COMPANY SNAPSHOT
TABLE 40.THERMO FISHER.: OPERATING SEGMENTS
TABLE 41.THERMO FISHER.: PRODUCT PORTFOLIO
TABLE 42.THERMO FISHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 01.SOUTH KOREA CELL CULTURE MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021 (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIER
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.MODERATE INTENSITY OF RIVALRY
FIGURE 10.LOW THREAT OF NEW ENTRANT
FIGURE 11.IMPACT ANALYSIS
FIGURE 12.MARKET SHARE ANALYSIS (SOUTH KOREA CULTURE MEDIA MARKET, 2019)
FIGURE 13.SOUTH KOREA CELL CULTURE MARKET FOR SERA, 2019-2027 ($MILLION)
FIGURE 14.SOUTH KOREA CELL CULTURE MARKET FOR MEDIA, 2019-2027 ($MILLION)
FIGURE 15.SOUTH KOREA CELL CULTURE MARKET FOR REAGENTS, 2019-2027 ($MILLION)
FIGURE 16.SOUTH KOREA CELL CULTURE MARKET FOR BIOREACTOR ACCESSORIES, 2019-2027 ($MILLION)
FIGURE 17.SOUTH KOREA CELL CULTURE MARKET FOR BIOREACTORS, 2019-2027 ($MILLION)
FIGURE 18.SOUTH KOREA CELL CULTURE MARKET FOR CELL CULTURE VESSELS, 2019-2027 ($MILLION)
FIGURE 19.SOUTH KOREA CELL CULTURE MARKET FOR CELL CULTURE STORAGE EQUIPMENT, 2019-2027 ($MILLION)
FIGURE 20.SOUTH KOREA CELL CULTURE MARKET FOR CELL CULTURE SUPPORTING INSTRUMENTS,
2019-2027 ($MILLION)
FIGURE 21.SOUTH KOREA CELL CULTURE MARKET FOR STEM CELL TECHNOLOGY, 2019-2027 ($MILLION)
FIGURE 22.SOUTH KOREA CELL CULTURE MARKET FOR CANCER RESEARCH, 2019-2027 ($MILLION)
FIGURE 23.SOUTH KOREA CELL CULTURE MARKET FOR DRUG SCREENING AND DEVELOPMENT, 2019-2027 ($MILLION)
FIGURE 24.SOUTH KOREA CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, 2019-2027 ($MILLION)
FIGURE 25.SOUTH KOREA CELL CULTURE MARKET FOR OTHERS, 2019-2027 ($MILLION)
FIGURE 26.SOUTH KOREA CELL CULTURE MARKET FOR RESEARCH INSTITUTES, 2019-2027 ($MILLION)
FIGURE 27.SOUTH KOREA CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 ($MILLION)
FIGURE 28.SOUTH KOREA CELL CULTURE MARKET FOR OTHERS, 2019-2027 ($MILLION)
FIGURE 29.AVANTOR: NET SALES, 2017–2019 ($MILLION)
FIGURE 30.AVANTOR: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 31.AVANTOR: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 32.BIO-RAD: NET SALES, 2017–2019 ($MILLION)
FIGURE 33.BIO-RAD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 34.BIO-RAD: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 35.CORNING: NET SALES, 2017–2019 ($MILLION)
FIGURE 36.CORNING: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 37.CORNING: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 38.DANAHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 39.DANAHER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 40.DANAHER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 41.FUJIFILM: NET SALES, 2017–2019 ($MILLION)
FIGURE 42.FUJIFILM: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 43.FUJIFILM: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 44.MERCK: NET SALES, 2017–2019 ($MILLION)
FIGURE 45.MERCK: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 46.MERCK: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 47.SARTORIUS: NET SALES, 2017–2019 ($MILLION)
FIGURE 48.SARTORIUS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 49.SARTORIUS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 50.THERMO FISHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 51.THERMO FISHER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 52.THERMO FISHER: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 01.SOUTH KOREA CELL CULTURE MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021 (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIER
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.MODERATE INTENSITY OF RIVALRY
FIGURE 10.LOW THREAT OF NEW ENTRANT
FIGURE 11.IMPACT ANALYSIS
FIGURE 12.MARKET SHARE ANALYSIS (SOUTH KOREA CULTURE MEDIA MARKET, 2019)
FIGURE 13.SOUTH KOREA CELL CULTURE MARKET FOR SERA, 2019-2027 ($MILLION)
FIGURE 14.SOUTH KOREA CELL CULTURE MARKET FOR MEDIA, 2019-2027 ($MILLION)
FIGURE 15.SOUTH KOREA CELL CULTURE MARKET FOR REAGENTS, 2019-2027 ($MILLION)
FIGURE 16.SOUTH KOREA CELL CULTURE MARKET FOR BIOREACTOR ACCESSORIES, 2019-2027 ($MILLION)
FIGURE 17.SOUTH KOREA CELL CULTURE MARKET FOR BIOREACTORS, 2019-2027 ($MILLION)
FIGURE 18.SOUTH KOREA CELL CULTURE MARKET FOR CELL CULTURE VESSELS, 2019-2027 ($MILLION)
FIGURE 19.SOUTH KOREA CELL CULTURE MARKET FOR CELL CULTURE STORAGE EQUIPMENT, 2019-2027 ($MILLION)
FIGURE 20.SOUTH KOREA CELL CULTURE MARKET FOR CELL CULTURE SUPPORTING INSTRUMENTS,
2019-2027 ($MILLION)
FIGURE 21.SOUTH KOREA CELL CULTURE MARKET FOR STEM CELL TECHNOLOGY, 2019-2027 ($MILLION)
FIGURE 22.SOUTH KOREA CELL CULTURE MARKET FOR CANCER RESEARCH, 2019-2027 ($MILLION)
FIGURE 23.SOUTH KOREA CELL CULTURE MARKET FOR DRUG SCREENING AND DEVELOPMENT, 2019-2027 ($MILLION)
FIGURE 24.SOUTH KOREA CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, 2019-2027 ($MILLION)
FIGURE 25.SOUTH KOREA CELL CULTURE MARKET FOR OTHERS, 2019-2027 ($MILLION)
FIGURE 26.SOUTH KOREA CELL CULTURE MARKET FOR RESEARCH INSTITUTES, 2019-2027 ($MILLION)
FIGURE 27.SOUTH KOREA CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 ($MILLION)
FIGURE 28.SOUTH KOREA CELL CULTURE MARKET FOR OTHERS, 2019-2027 ($MILLION)
FIGURE 29.AVANTOR: NET SALES, 2017–2019 ($MILLION)
FIGURE 30.AVANTOR: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 31.AVANTOR: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 32.BIO-RAD: NET SALES, 2017–2019 ($MILLION)
FIGURE 33.BIO-RAD: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 34.BIO-RAD: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 35.CORNING: NET SALES, 2017–2019 ($MILLION)
FIGURE 36.CORNING: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 37.CORNING: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 38.DANAHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 39.DANAHER: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 40.DANAHER: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 41.FUJIFILM: NET SALES, 2017–2019 ($MILLION)
FIGURE 42.FUJIFILM: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 43.FUJIFILM: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 44.MERCK: NET SALES, 2017–2019 ($MILLION)
FIGURE 45.MERCK: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 46.MERCK: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 47.SARTORIUS: NET SALES, 2017–2019 ($MILLION)
FIGURE 48.SARTORIUS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 49.SARTORIUS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 50.THERMO FISHER: NET SALES, 2017–2019 ($MILLION)
FIGURE 51.THERMO FISHER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 52.THERMO FISHER: REVENUE SHARE, BY REGION, 2019 (%)
